Zorbtive and nephrolithiasis Patient Reports February 11, 2012

Zorbtive Side Effects Report #5689862-8
Zorbtive side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, 54 years of age, weighting 129.2 lb, was diagnosed with gastrointestinal disorder and was treated with Zorbtive. After drug was administered, patient experienced the following side effects: bacteraemia, diarrhoea, nephrolithiasis. Zorbtive dosage: 6.0MG QD SUBCUTANEOUS. During the same period patient was treated with COREG, ZOCOR, POTASSIUM CHLORIDE, CODEINE SUL, PREVACID, ASPIRIN. Patient was hospitalized. Patient recovered.